創新奇智(02121.HK)與亨利加(03638.HK)就區塊鏈等業務合組公司
創新奇智(02121.HK)公佈,全資附屬公司與亨利加(03638.HK)的一家全資附屬公司共同成立了一家名爲亨利加數鏈科技有限公司的合營公司,亨利加與其分別持有合營公司80%及20%的權益。合營公司將主要從事圍繞金融服務、人工智能及區塊鏈應用等領域的業務,包括建設面向金融行業的智能化區塊鏈應用與整體解決方案,提供「技術+業務+應用開發」三位一體服務,以及推進基於區塊鏈技術的現實世界資產和企業支付穩定幣系統等第三代互聯網應用及配套解決方案服務落地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.